Navigation Links
Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile

» The Danish Statens Serum Institut (SSI) and Intercell report promising data
from a phase I clinical trial with a tuberculosis (TB) subunit vaccine

» The vaccine is produced by SSI and contains Intercell’s adjuvant IC31™

» The project which is supported by the European Union aims to either
replace the available TB vaccine “BCG”/“Calmette vaccine” or to
boost its activity in adults.

COPENHAGEN, Vienna, March 14, 2007 – Statens Serum Institut (SSI) and Intercell announced today that their collaborative novel tuberculosis (TB) vaccine is safe and very immunogenic in healthy individuals in a phase I clinical trial. The preliminary data will be presented on the Keystone Symposia on Tuberculosis in Vancouver, March 24, 2007 by Prof. Peter Andersen from the SSI and April 12, 2007 at the 3rd Vienna Vaccines Conference by co-investigator Prof. Tom Ottenhoff, Leiden University Medical Center, Netherlands. Based on these results the partners will initiate a clinical trial with latent TB-infected and BCG-vaccinated individuals later in 2007.

The new H1 vaccine from SSI is a recombinant subunit vaccine based on two important TB antigens resulting from SSI’s research pipeline combined with Intercell’s proprietary adjuvant IC31™. The phase I clinical trial was performed at the Department of Infectious Diseases (headed by Prof. Jaap van Dissel) at Leiden University Medical Center in the Netherlands and was supported by the European Union–funded program “TB-VAC”.

“The successfu
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
9. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
10. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
11. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting

Post Your Comments:
(Date:11/20/2009)... The National Association of Drug D...ew initiative in the war on methamphetamine. The ...-state electronic tracking program that enforces p...cines containing pseudoephedrine in real-time at t...ed on a system that was developed and tested in Ke...
(Date:11/20/2009)...wswire/ -- Reportlinker.com announces that a new m...e. ,, Global Self Monitoring Blood Glucose Mar..., http://www.reportlinker.com/p0164657/Global...easing-Adoption-to-Drive-Growth.html#utm_source=pr...wire ,, Description ,, Global Self Monito...
(Date:11/20/2009)...wswire/ -- Reportlinker.com announces that a new m...e. ,, Medical Adhesives and Sealants - A US Ma...0164242/Medical-Adhesives-and-Sealants---A-US-Mark...m=pr&utm_campaign=prnewswire ,, The use o...nence in medical devices and equipments. Cutting e...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 1RadMD First to Offer CME Certified Education and Training For Medical Imaging in Clinical Trials 13230 2FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 1FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 2FDA Warnings on Mercury Tooth Fillings Expected Today 3A New Regulation Result of Lawsuit Settled Last Year 52911 3Kendle Realigns C Suite Leadership to Drive Increased Innovation Productivity and Organizational Efficiency 13228 1Kendle Realigns C Suite Leadership to Drive Increased Innovation Productivity and Organizational Efficiency 13228 2Kendle Realigns C Suite Leadership to Drive Increased Innovation Productivity and Organizational Efficiency 13228 3
...Jun 21, 2007 - Nymox,Pharmaceutical Corporation (N... from the Company,s recently completed studies of,...l be presented at,a series of upcoming U.S. urolog...ntral American Urological Association Meeting in,C...tions will be,given by leading clinical research u...
...“In anaplastic,astrocytoma, AP 12009 as a mo...mide,” Prof. Albert Wong, M.D., Stanford,Uni...national Phase,IIb study with the TGF-beta 2-inhib...ma. Prof. Wong discussed the results of the study,...s system tumors,at the 43rd Annual Meeting of the ...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
(Date:11/21/2009)... , "This bill provides for an unprecedente...health care about if it is not for preserving and ... it must be defeated." Charmaine Yoest ,, WA...cans United for Life Action President and CEO Dr. ... Senate by releasing the following statement: ,...
(Date:11/21/2009)..., LONDON, November 21, 2009 /PRNewswire-Fir... Test Test Test Test Test Test Test Test Test Test... Test Test Test Test Test Test,Test Test Test Test... More test More test More test More test More tes...t More test More test More test More test More,tes...
(Date:11/21/2009)... Eric J. Hall, president and c...on of America (AFA) issued the following statement...etection as part of the new annual wellness for Me...on and Affordable Care Act" that was introduc..., NY (PRWEB) November 21, 2009 -- Eric J. Hall, pr...
(Date:11/20/2009)... , PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCal... that a Special Meeting of Shareholders will be he...e Meeting is to consider approval of two special r...rove and authorize the sale of all or substantiall...he terms provided for in the asset purchase agreem...
(Date:11/20/2009)... Senators and Congressmen in C... Over their Health Care Vote , ...Senators and congressmen running for re-election n...tical guru Charlie Cook, may come to regret voting...e bill, according to a breaking Zogby Internationa...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...(Nasdaq: MYL ) today announced that its subsidia...vals from the U.S. Food and Drug Administration (F...As) for Mycophenolate Mofetil Tablets, 500 mg, and...n of organ rejection in patients receiving kidney,...
...e H1N1 virus in six hours or less , , HUNTSVILLE,...iatherix.com ) today released the first clinicall...e current strain of H1N1 virus, also known as the ...he rapid confirmation of suspected H1N1 patients. ...
...oss of as little as $500 would have "severe" impac... 7 As unemployment rates continue to climb, one o... their access to affordable insurance. In a nation...o-paycheck "often" or "always." The survey questio...
...poration (Nasdaq: AIRM ) announces the following...poration Webcast, When: Thursday, May ...ideonewswire.com/event.asp?id=58279 , How: ...ive Webcast, the call, will be archived on t...
...xis, Inc. (Nasdaq: ABAX ), a medical products co...ystems, announced today that Don Wood, chief opera... and Merrill Lynch 2009 Health Care Conference on ...sten to a live audio webcast of the Company,s pres...
...ens from ACUVUE(R) in 11 years combines unique Ste... senofilcon A material to help contact lens wearer... May 7 VISTAKON(R), Division of Johnson & Joh...new multifocal contact lens from the makers of ACU...
Other Medicine News:Health News:Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus 2Health News:Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus 3Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 2Health News:Affinion Group Survey Reveals That Underinsured Consumers Need Alternate Solutions in Light of Current Economic Climate 3Health News:Abaxis, Inc. to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 2Health News:VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA 2Health News:VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA 3Health News:VISTAKON to Introduce ACUVUE(R) OASYS(TM) Brand Contact Lenses for PRESBYOPIA 4
...ep A Test is a color immunochromatographic assay u...ody labeled color particles coated at two separate...sensitivity than the conventional single label tec...st procedure, a throat swab is subjected to a chem...
... test is an easy to use, one step, lateral flow ra...s of determining the amount of follicle stimulatin...e test is performed two days after the onset of me... in design and use to a pregnancy test or an ovula...
... System delivers an unmatched combination of speed...olution for assessing and monitoring a patient's A...ere ., ,The CLIA-waived Cholestech GDX requ...sults in less than 5 minutes. The system is a prov...
... System, using patented, innovative technology, me...LT in only 5 minutes from a simple fingerstick. Wi...unction results. The scope of its measurement capa...roviders. The physician, nurse or technician can n...
Medicine Products: